Suman Prinjha1, Julie Evans, Ann McPherson. 1. DIPEx, Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford OX3 7LF, England. sbprinjha@hotmail.com
Abstract
OBJECTIVES: To explore the attitudes of women with screen-detected ductal carcinoma in situ (DCIS) towards information provision for mammographic screening. SETTING: Respondents recruited throughout the UK during 2003-2004. METHODS: Qualitative study using semi-structured interviews. PARTICIPANTS: Ten women diagnosed with DCIS as a result of mammographic screening. RESULTS: None of the women with DCIS had heard of it before their diagnosis. Most would have liked more information about DCIS when invited for routine screening. Comprehensive information about the benefits and risks of mammographic screening, including the possibility of a DCIS diagnosis, would have enabled them to make a fully informed choice about attending for screening. CONCLUSION: DCIS is an inescapable outcome of mammographic screening and, until it is better understood, the screening industry needs to inform women about its existence and the lack of understanding of its natural history and management. Being alerted before screening to the possibility of a DCIS diagnosis and the uncertainty associated with it would better enable women to make fully informed decisions about whether to attend and could help to alleviate some of the distress women currently feel when diagnosed with DCIS.
OBJECTIVES: To explore the attitudes of women with screen-detected ductal carcinoma in situ (DCIS) towards information provision for mammographic screening. SETTING: Respondents recruited throughout the UK during 2003-2004. METHODS: Qualitative study using semi-structured interviews. PARTICIPANTS: Ten women diagnosed with DCIS as a result of mammographic screening. RESULTS: None of the women with DCIS had heard of it before their diagnosis. Most would have liked more information about DCIS when invited for routine screening. Comprehensive information about the benefits and risks of mammographic screening, including the possibility of a DCIS diagnosis, would have enabled them to make a fully informed choice about attending for screening. CONCLUSION: DCIS is an inescapable outcome of mammographic screening and, until it is better understood, the screening industry needs to inform women about its existence and the lack of understanding of its natural history and management. Being alerted before screening to the possibility of a DCIS diagnosis and the uncertainty associated with it would better enable women to make fully informed decisions about whether to attend and could help to alleviate some of the distress women currently feel when diagnosed with DCIS.
Authors: Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt Journal: CA Cancer J Clin Date: 2012-04-04 Impact factor: 508.702
Authors: Linn Abraham; Berta M Geller; Bonnie C Yankaskas; Erin J A Bowles; Leah S Karliner; Stephen H Taplin; Diana L Miglioretti Journal: Breast Cancer Res Treat Date: 2009-03-20 Impact factor: 4.872
Authors: George Dowswell; Angela Ryan; Aliki Taylor; Amanda Daley; Nick Freemantle; Matthew Brookes; Janet Jones; Richard Haslop; Chloe Grimmett; Kar-Keung Cheng; Wilson Sue Journal: BMC Cancer Date: 2012-06-18 Impact factor: 4.430
Authors: Claire Kim; Laurel Liang; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi Journal: Breast Cancer Res Treat Date: 2017-12-23 Impact factor: 4.872
Authors: Bryanna B Nyhof; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Nancy N Baxter; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi Journal: Health Expect Date: 2019-09-18 Impact factor: 3.377